Intervention Study on Digital Health Management
Launched by SHANGHAI 10TH PEOPLE'S HOSPITAL · Apr 21, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new digital health system designed to help people with certain heart and metabolic conditions, specifically hypertension (high blood pressure) and high cholesterol. The goal is to create a personalized program that closely monitors patients' health using wearable devices. These devices will track important health indicators like blood pressure, blood sugar, and cholesterol levels. By analyzing individual risk factors such as genetics, lifestyle, and emotional well-being, the study aims to provide tailored recommendations for improving health and reducing the risk of serious heart-related issues.
To participate in this trial, you need to be between 18 and 65 years old and meet certain health criteria, such as having mild high blood pressure or high cholesterol, but you shouldn't be on any medications for these conditions yet. Participants will use a smartphone to access the digital system and can expect to receive continuous support and feedback on their health. It's important to know that individuals with more severe health issues, like heart disease or certain cancers, won't be eligible to join. This study represents a promising step towards more effective and personalized management of chronic health problems.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:1. Age 18-65 years old; 2. Meet one of the following three conditions:
- • 1. Diastolic hypertension (systolic blood pressure \< 140 MMHG and diastolic blood pressure ≥90mmHg)
- • 2. Glycosylated hemoglobin (6.0-6.5)
- • 3. Obesity (BMI≥28kg/m²)
- • 4. Mild hyperlipemia: total cholesterol (TC) ≥5.2 mmol/L and \< 6.2 mmol/L, or low-density lipoprotein cholesterol (LDL-C) ≥3.4 mmol/L and \< 4.1 mmol/L 3. Antihypertensive or lipid-lowering medications have not been started 4. Use a smartphone and volunteer
- Exclusion Criteria:
- • 1. Complicated with chronic liver and kidney disease, coronary heart disease, heart failure and severe valvular disease
- • 2. Previous cardiovascular and cerebrovascular events
- • 3. Diastolic blood pressure ≥99mmHg
- • 4. Glycated hemoglobin ≥6.5
- • 5. Other life expectancy such as cancer is less than 5 years
- • 6. Participate in other clinical trials
About Shanghai 10th People's Hospital
Shanghai 10th People's Hospital, affiliated with Tongji University, is a leading clinical research institution in China known for its commitment to advancing medical science and improving patient care. With a focus on innovative therapies and cutting-edge research methodologies, the hospital conducts a wide range of clinical trials across various medical disciplines. Its state-of-the-art facilities and multidisciplinary team of experts enable rigorous study designs and high-quality data collection, fostering collaboration with both national and international partners. The hospital is dedicated to upholding ethical standards and promoting patient safety, ensuring that its clinical trials contribute significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported